Mental awareness improved mild cognitive impairment and modulated gut microbiome

Wei Wei Thwe Khine, Miao Lian Voong, Ted Kheng Siang Ng, Lei Feng, Grishma Avinash Rane, Alan Prem Kumar, Ee Heok Kua, Ratha Mahendran, Rathi Mahendran, Yuan-Kun Lee, Wei Wei Thwe Khine, Miao Lian Voong, Ted Kheng Siang Ng, Lei Feng, Grishma Avinash Rane, Alan Prem Kumar, Ee Heok Kua, Ratha Mahendran, Rathi Mahendran, Yuan-Kun Lee

Abstract

There is ample scientific and clinical evidence of the effects of gut microbiota on the brain but no definitive evidence that the brain can affect changes in gut microbiota under the bi-directional gut-brain axis concept. As there is no pharmacotherapeutic intervention for the early stages of cognitive decline, research has focused on cognitive stimulation in reversing or slowing the impairment. Elderly patients diagnosed with mild cognitive impairment underwent a randomized-control trial of mindful awareness practice. Neuropsychological assessments, inflammatory markers, and gut microbiota profiles were tested. Here, we report that their cognitive impairment was improved and associated with changes in gut bacterial profile. A cognition-score-dependent-abundance was observed in Ruminococcus vs Recognition Trials (RT), Digit Span Backward (DSB), Semantic Fluency Span (SFS) and Memory Domain (MD); Coprococcus vs DSB, Color Trails Test 2 (CTT2) and Block Design (BD); Parabacteroides vs DSB and SFS; Fusobacterium vs DSB and CTT2; Enterobacteriaceae vs BD and SFS; Ruminococcaceae vs DSB; Phascolarctobacterium vs MD. The study showed for the first-time, alteration in the cognitive capacity leading to the corresponding changes in microbiota profiles. This strongly suggests that signals from the different segments of brain could dictate directly or indirectly the abundances of specific gut microbes.

Keywords: gut-brain axis; mental health; microbiome; mild cognitive impairment; mindful awareness practice.

Conflict of interest statement

CONFLICTS OF INTEREST: The authors declare no conflicts of financial interests.

Figures

Figure 1
Figure 1
(A, B) The distribution of microbiota profiles among Normal Aging and Mindful Awareness Program (MAP) groups. (A) A distance-based redundancy analysis (db-RDA) plot. (B) species biplot describes 1 % and above of the bacterial genera distribution in the db-RDA plane. The groups of the subjects are represented by four different color-coded symbols with sample size in parenthesis in the legend.
Figure 2
Figure 2
Alpha and beta diversity of Normal Aging and MAP groups. (A) Chao 1’s, (B) Shannon’s alpha diversity indexes comparing Normal Aging and three time points of MAP groups. p* values of Mann-Whitney U test described significant difference from each other at two-sided p values of 0.05. In each box plot, median line, + mean, upper and lower quartiles, upper and lower extremes and whiskers are presented. (C) Weighted (D) Unweighted Unifrac principal coordinates analysis (PCoA) for beta diversity comparing Normal Aging and three time points of MAP groups. The groups of the subjects are represented by four different color-coded symbols with sample size in parenthesis in the legend. MAP= Mindful Awareness Program.
Figure 3
Figure 3
Nutritional intake of Normal Aging and MCI subjects. Overall nutritional intake comparing two groups of the subject. Two-tailed p values calculated by non-parametric Mann-Whitney U-test were described in the individual box plots and presented as ** p ≥ 0.001 - < 0.01, * p ≥ 0.01- < 0.05. In each box plot, median line, + mean, upper and lower quartiles, upper and lower extremes and whiskers are presented. The groups of the subjects are represented by two different color-coded symbols with sample size in parenthesis in the legend. MCI= Mild cognitive impairment.
Figure 4
Figure 4
Neuropsychological tests of MCI subjects, which showed differences with Normal Aging subjects, and during MAP intervention study. Significant different p values (two-tailed, at p= 0.05) of Mann-Whitney U test are described comparing two groups and presented as **** p < 0.0001, *** p ≥ 0.0001 - < 0.001, ** p ≥ 0.001 - < 0.01, * p ≥ 0.01- < 0.05. In each box plot, median line, + mean, upper and lower quartiles, upper and lower extremes and whiskers are presented. The groups of the subjects represented by four different color-coded symbols with sample size are indicated in parenthesis in the legend. MCI= Mild cognitive impairment, MAP= Mindful awareness program.
Figure 5
Figure 5
Comparison of four blood biomarkers in Normal Aging and MAP groups. (A) Mean of telomere length over time in the MAP intervention study. P values were calculated by Wilcoxon matched-pairs signed-rank t test comparing the two groups. The samples of Normal Aging were not measured for telomere length. (B) Concentrations of BDNF (pg/ml), (C) DHEAS (ng/ml) and (D) hs-CRP (μg/ml) comparing Normal Aging and three timepoints of MAP groups. Significant different two-tailed p values of Mann-Whitney U test are presented as **** p < 0.0001, *** p ≥ 0.0001 - < 0.001, ** p ≥ 0.001 - < 0.01, * p ≥ 0.01- < 0.05. In each box plot, median line, + mean, upper and lower quartiles, upper and lower extremes and whiskers are presented. The groups of the subjects represented by three different color-coded symbols with sample size are indicated in parenthesis in the legend. MAP= Mindful Awareness Program, BDNF= Brain-derived neurotrophic factor, DHEAS= Dehydroepiandrosterone sulfate, hs-CRP= High sensitive C-reactive protein.
Figure 6
Figure 6
Comparison of fecal water cytokines in Normal Aging and MAP groups. Concentration of 11 fecal water cytokines (pg/ml) are described in each box plot comparing Normal Aging and three timepoints of MAP groups. Significant different two-tailed p values of Mann-Whitney U test are presented as **** p < 0.0001, *** p ≥ 0.0001 - < 0.001, ** p ≥ 0.001 - < 0.01, * p ≥ 0.01- < 0.05. In each box plot, median line, + mean, upper and lower quartiles, upper and lower extremes and whiskers are presented. The groups of the subjects represented by three different color-coded symbols with sample size are indicated in parenthesis in the legend. MAP= Mindful awareness program, IL= Interleukin, IL-1β= Interleukin-1 beta, TNFα= Tumor necrosis factor alpha, IFNγ= Interferon gamma, GM-CSG= Granulocyte-macrophage colony-stimulating factor.
Figure 7
Figure 7
Correlation between Z scores of neuropsychological tests and relative abundances of major gut bacterial genus (>1% of total OTU) of three timepoints of MAP groups. In the heatmap, Spearman correlation coefficient rho (r) are presented in red (positive correlation), white (no correlation) and green (negative correlation). The significant different correlations are presented as **** p < 0.0001, *** p ≥ 0.0001 - < 0.001, ** p ≥ 0.001 - < 0.01, * p ≥ 0.01- < 0.05. The p values were corrected by false discovery rate using the Benjamini and Hochberg method and q values were represented as # q ≥ 0.01- < 0.05. OTU= Operational taxonomical unit, MAP= Mindful awareness program, UG= Unknown genus, UF= Unknown family. MAP (both correlation parameters); n= 53 (Timepoint 1; n= 28, Timepoint 2; n= 21, Timepoint 3; n= 14).

References

    1. Kowalski K, Mulak A. Brain-gut-microbiota axis in Alzheimer’s disease. J Neurogastroenterol Motil. 2019; 25:48–60. 10.5056/jnm18087
    1. Caracciolo B, Xu W, Collins S, Fratiglioni L. Cognitive decline, dietary factors and gut-brain interactions. Mech Ageing Dev. 2014; 136:59–69. 10.1016/j.mad.2013.11.011
    1. Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: the links with dementia development. Protein Cell. 2017; 8:90–102. 10.1007/s13238-016-0338-6
    1. Rawtaer I, Mahendran R, Yu J, Fam J, Feng L, Kua EH. Psychosocial interventions with art, music, Tai Chi and mindfulness for subsyndromal depression and anxiety in older adults: a naturalistic study in Singapore. Asia Pac Psychiatry. 2015; 7:240–50. 10.1111/appy.12201
    1. Fam J, Sun Y, Qi P, Lau RC, Feng L, Kua EH, Mahendran R. Mindfulness practice alters brain connectivity in community-living elders with mild cognitive impairment. Psychiatry Clin Neurosci. 2020; 74:257–62. 10.1111/pcn.12972
    1. Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness, 15th Edition. Delta Trade, New York: 2005.
    1. Jha AP, Krompinger J, Baime MJ. Mindfulness training modifies subsystems of attention. Cogn Affect Behav Neurosci. 2007; 7:109–19. 10.3758/cabn.7.2.109
    1. Shonin E, Van Gordon W, Griffiths MD. Mindfulness-based interventions: towards mindful clinical integration. Front Psychol. 2013; 4:194. 10.3389/fpsyg.2013.00194
    1. Gard T, Hölzel BK, Lazar SW. The potential effects of meditation on age-related cognitive decline: a systematic review. Ann N Y Acad Sci. 2014; 1307:89–103. 10.1111/nyas.12348
    1. Wells RE, Kerr CE, Wolkin J, Dossett M, Davis RB, Walsh J, Wall RB, Kong J, Kaptchuk T, Press D, Phillips RS, Yeh G. Meditation for adults with mild cognitive impairment: a pilot randomized trial. J Am Geriatr Soc. 2013; 61:642–5. 10.1111/jgs.12179
    1. Davidson RJ, Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D, Santorelli SF, Urbanowski F, Harrington A, Bonus K, Sheridan JF. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med. 2003; 65:564–70. 10.1097/01.psy.0000077505.67574.e3
    1. Creswell JD, Irwin MR, Burklund LJ, Lieberman MD, Arevalo JM, Ma J, Breen EC, Cole SW. Mindfulness-based stress reduction training reduces loneliness and pro-inflammatory gene expression in older adults: a small randomized controlled trial. Brain Behav Immun. 2012; 26:1095–101. 10.1016/j.bbi.2012.07.006
    1. Black DS, Slavich GM. Mindfulness meditation and the immune system: a systematic review of randomized controlled trials. Ann N Y Acad Sci. 2016; 1373:13–24. 10.1111/nyas.12998
    1. Ng TK, Fam J, Feng L, Cheah IK, Tan CT, Nur F, Wee ST, Goh LG, Chow WL, Ho RC, Kua EH, Larbi A, Mahendran R. Mindfulness improves inflammatory biomarker levels in older adults with mild cognitive impairment: a randomized controlled trial. Transl Psychiatry. 2020; 10:21. 10.1038/s41398-020-0696-y
    1. Epel E, Daubenmier J, Moskowitz JT, Folkman S, Blackburn E. Can meditation slow rate of cellular aging? cognitive stress, mindfulness, and telomeres. Ann N Y Acad Sci. 2009; 1172:34–53. 10.1111/j.1749-6632.2009.04414.x
    1. Dash S, Clarke G, Berk M, Jacka FN. The gut microbiome and diet in psychiatry: focus on depression. Curr Opin Psychiatry. 2015; 28:1–6. 10.1097/YCO.0000000000000117
    1. Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The central nervous system and the gut microbiome. Cell. 2016; 167:915–32. 10.1016/j.cell.2016.10.027
    1. Rieder R, Wisniewski PJ, Alderman BL, Campbell SC. Microbes and mental health: a review. Brain Behav Immun. 2017; 66:9–17. 10.1016/j.bbi.2017.01.016
    1. O’Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015; 277:32–48. 10.1016/j.bbr.2014.07.027
    1. Köhler CA, Maes M, Slyepchenko A, Berk M, Solmi M, Lanctôt KL, Carvalho AF. The gut-brain axis, including the microbiome, leaky gut and bacterial translocation: mechanisms and pathophysiological role in Alzheimer’s disease. Curr Pharm Des. 2016; 22:6152–66. 10.2174/1381612822666160907093807
    1. Lowry CA, Smith DG, Siebler PH, Schmidt D, Stamper CE, Hassell JE Jr, Yamashita PS, Fox JH, Reber SO, Brenner LA, Hoisington AJ, Postolache TT, Kinney KA, et al.. The microbiota, immunoregulation, and mental health: implications for public health. Curr Environ Health Rep. 2016; 3:270–86. 10.1007/s40572-016-0100-5
    1. Pisanu C, Squassina A. We are not Alone in Our Body: Insights into the Involvement of Microbiota in the Etiopathogenesis and Pharmacology of Mental Illness. Curr Drug Metab. 2018; 19:688–694. 10.2174/1389200219666171227204144
    1. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990; 345:458–60. 10.1038/345458a0
    1. Frenck RW Jr, Blackburn EH, Shannon KM. The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci USA. 1998; 95:5607–10. 10.1073/pnas.95.10.5607
    1. Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, Schneider HG, Leonard BE, Berk M. Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry. 2010; 197:372–77. 10.1192/bjp.bp.109.076430
    1. Kivimäki M, Shipley MJ, Batty GD, Hamer M, Akbaraly TN, Kumari M, Jokela M, Virtanen M, Lowe GD, Ebmeier KP, Brunner EJ, Singh-Manoux A. Long-term inflammation increases risk of common mental disorder: a cohort study. Mol Psychiatry. 2014; 19:149–50. 10.1038/mp.2013.35
    1. Zhang J, Rane G, Dai X, Shanmugam MK, Arfuso F, Samy RP, Lai MK, Kappei D, Kumar AP, Sethi G. Ageing and the telomere connection: an intimate relationship with inflammation. Ageing Res Rev. 2016; 25:55–69. 10.1016/j.arr.2015.11.006
    1. Mufson EJ, Counts SE, Fahnestock M, Ginsberg SD. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Curr Alzheimer Res. 2007; 4:340–50. 10.2174/156720507781788855
    1. Tanila H. The role of BDNF in Alzheimer’s disease. Neurobiol Dis. 2017; 97:114–18. 10.1016/j.nbd.2016.05.008
    1. Piazza JR, Almeida DM, Dmitrieva NO, Klein LC. Frontiers in the use of biomarkers of health in research on stress and aging. J Gerontol B Psychol Sci Soc Sci. 2010; 65:513–25. 10.1093/geronb/gbq049
    1. Yiallouris A, Tsioutis C, Agapidaki E, Zafeiri M, Agouridis AP, Ntourakis D, Johnson EO. Adrenal aging and its implications on stress responsiveness in humans. Front Endocrinol (Lausanne). 2019; 10:54. 10.3389/fendo.2019.00054
    1. Nakayama J, Watanabe K, Jiang J, Matsuda K, Chao SH, Haryono P, La-Ongkham O, Sarwoko MA, Sujaya IN, Zhao L, Chen KT, Chen YP, Chiu HH, et al.. Diversity in gut bacterial community of school-age children in Asia. Sci Rep. 2015; 5:8397. 10.1038/srep08397
    1. Nakayama J, Yamamoto A, Palermo-Conde LA, Higashi K, Sonomoto K, Tan J, Lee YK. Impact of westernized diet on gut microbiota in children on leyte island. Front Microbiol. 2017; 8:197. 10.3389/fmicb.2017.00197
    1. Kisuse J, La-Ongkham O, Nakphaichit M, Therdtatha P, Momoda R, Tanaka M, Fukuda S, Popluechai S, Kespechara K, Sonomoto K, Lee YK, Nitisinprasert S, Nakayama J. Urban diets linked to gut microbiome and metabolome alterations in children: a comparative cross-sectional study in Thailand. Front Microbiol. 2018; 9:1345. 10.3389/fmicb.2018.01345
    1. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010; 107:14691–96. 10.1073/pnas.1005963107
    1. Khine WW, Zhang Y, Goie GJ, Wong MS, Liong M, Lee YY, Cao H, Lee YK. Gut microbiome of pre-adolescent children of two ethnicities residing in three distant cities. Sci Rep. 2019; 9:7831. 10.1038/s41598-019-44369-y
    1. Seganfredo FB, Blume CA, Moehlecke M, Giongo A, Casagrande DS, Spolidoro JV, Padoin AV, Schaan BD, Mottin CC. Weight-loss interventions and gut microbiota changes in overweight and obese patients: a systematic review. Obes Rev. 2017; 18:832–51. 10.1111/obr.12541
    1. Singer-Englar T, Barlow G, Mathur R. Obesity, diabetes, and the gut microbiome: an updated review. Expert Rev Gastroenterol Hepatol. 2019; 13:3–15. 10.1080/17474124.2019.1543023
    1. Bercik P. The microbiota-gut-brain axis: learning from intestinal bacteria? Gut. 2011; 60:288–89. 10.1136/gut.2010.226779
    1. Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, Macqueen G, Sherman PM. Bacterial infection causes stress-induced memory dysfunction in mice. Gut. 2011; 60:307–17. 10.1136/gut.2009.202515
    1. Claesson MJ, Jeffery IB, Conde S, Power SE, O’Connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O’Sullivan O, Fitzgerald GF, Deane J, O’Connor M, et al.. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012; 488:178–84. 10.1038/nature11319
    1. Diagnostic and statistical manual of mental disorders, 5th Edition. American Psychiatric Association, Washington, DC: 2013. 10.1176/appi.books.9780890425596
    1. McBee L. Mindfulness-based elder care: A CAM model for frail elders and their caregivers. Springer Publishing Co. 2008. 10.1007/978-0-387-09593-6_24
    1. McBee L. Chapter 11- I am sure to grow old: mindfulness-based elder care. In: Mindfulness-based treatment approaches. Elsevier; 2014:239–65. 10.1016/B978-0-12-416031-6.00011-6
    1. Report of the National Nutrition Survey, Health Promotion Board, Singapore 2004.
    1. Energy & nutrient composition of food, Health Promotion Board, Singapore 2011. .
    1. Feng L, Chong MS, Lim WS, Ng TP. The modified mini-mental state examination test: normative data for Singapore Chinese older adults and its performance in detecting early cognitive impairment. Singapore Med J. 2012; 53:458–62.
    1. Berg L. Clinical dementia rating (CDR). Psychopharmacol Bull. 1988; 24:637–39.
    1. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982; 140:566–72. 10.1192/bjp.140.6.566
    1. Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993; 43:2412–14. 10.1212/wnl.43.11.2412-a
    1. Rey A. L'examen clinique en psychologie [The clinical examination in psychology]. Presses Universitaries De France, Paris: (1964).
    1. Fernaeus SE, Ostberg P, Wahlund LO, Hellström A. Memory factors in rey AVLT: implications for early staging of cognitive decline. Scand J Psychol. 2014; 55:546–53. 10.1111/sjop.12157
    1. Martín ME, Sasson Y, Crivelli L, Roldán Gerschovich E, Campos JA, Calcagno ML, Leiguarda R, Sabe L, Allegri RF. Relevance of the serial position effect in the differential diagnosis of mild cognitive impairment, Alzheimer-type dementia, and normal ageing. Neurologia. 2013; 28:219–25. 10.1016/j.nrl.2012.04.013
    1. Wechsler D. Wechsler Adult Intelligence scale (WAIS-IV), 4th Edition. Pearson, The psychological corporation; (2008). 10.1037/t15169-000
    1. Yin S, Zhu X, Huang X, Li J. Visuospatial characteristics of an elderly Chinese population: results from the WAIS-R block design test. Front Aging Neurosci. 2015; 7:17. 10.3389/fnagi.2015.00017
    1. Maj M, D'Elia L, Satz P, Janssen R, Zaudig M, Uchiyama C, Starace F, Galderisi S, Chervinsky A, and World Health Organization, Division of Mental Health/Global Programme on AIDS. Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch Clin Neuropsychol. 1993; 8:123–35.
    1. D’Elia LF, Satz P, Uchiyama CL & White T. Color Trails test. PAR, Odessa, FL: 1997.
    1. Newcombe F. Missile wounds of the brain: a study of psychological deficits. Oxford University Press, Oxford: 1969.
    1. Ardila A, Ostrosky-Solis F & Bernal B. Cognitive testing toward the future: the example of semantic verbal fluency (animals). International J of Psychology. 2006; 41:324–332. 10.1080/00207590500345542
    1. Zhao Q, Guo Q, Hong Z. Clustering and switching during a semantic verbal fluency test contribute to differential diagnosis of cognitive impairment. Neurosci Bull. 2013; 29:75–82. 10.1007/s12264-013-1301-7
    1. Nyunt MS, Fones C, Niti M, Ng TP. Criterion-based validity and reliability of the geriatric depression screening scale (GDS-15) in a large validation sample of community-living Asian older adults. Aging Ment Health. 2009; 13:376–82. 10.1080/13607860902861027
    1. Pachana NA, Byrne GJ, Siddle H, Koloski N, Harley E, Arnold E. Development and validation of the geriatric anxiety inventory. Int Psychogeriatr. 2007; 19:103–14. 10.1017/S1041610206003504
    1. Pachana NA. & Byrne GJ. The geriatric anxiety inventory: international use and future directions. Australian Psychological Society. 2012; 47:33–38. 10.1111/j.1742-9544.2011.00052.x
    1. Lee CK, Collinson SL, Feng L, Ng TP. Preliminary normative neuropsychological data for an elderly Chinese population. Clin Neuropsychol. 2012; 26:321–34. 10.1080/13854046.2011.652180
    1. Malarkey WB, Jarjoura D, Klatt M. Workplace based mindfulness practice and inflammation: a randomized trial. Brain Behav Immun. 2013; 27:145–54. 10.1016/j.bbi.2012.10.009
    1. Parikh TP, Stolze B, Ozarda Y, Jonklaas J, Welsh K, Masika L, Hill M, DeCherney A, Soldin SJ. Diurnal variation of steroid hormones and their reference intervals using mass spectrometric analysis. Endocr Connect. 2018; 7:1354–361. 10.1530/EC-18-0417
    1. Kimura M, Stone RC, Hunt SC, Skurnick J, Lu X, Cao X, Harley CB, Aviv A. Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths. Nat Protoc. 2010; 5:1596–607. 10.1038/nprot.2010.124
    1. Göhring J, Fulcher N, Jacak J, Riha K. TeloTool: a new tool for telomere length measurement from terminal restriction fragment analysis with improved probe intensity correction. Nucleic Acids Res. 2014; 42:e21. 10.1093/nar/gkt1315
    1. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, et al.. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010; 7:335–36. 10.1038/nmeth.f.303
    1. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010; 26:2460–61. 10.1093/bioinformatics/btq461
    1. Albanese D, Fontana P, De Filippo C, Cavalieri D, Donati C. MICCA: a complete and accurate software for taxonomic profiling of metagenomic data. Sci Rep. 2015; 5:9743. 10.1038/srep09743
    1. Wickham H. ggplot2: Elegant graphics for data analysis. Springer-Verlag, New York: 2016. 10.1007/978-3-319-24277-4_9
    1. Martinez AP. PairwiseAdonis: pairwise multilevel comparison using adonis. R package version 0.3. 2019.

Source: PubMed

3
Subscribe